"Anything we can do to try to make that process more predictable, to create bright lines, to use better tools to evaluate safety and effectiveness that could bring down the cost."
"I come back to the Cures Act because I think that there is a lot of opportunity for that to be a template for policymaking in this regard."
"I applaud the commitment to patient-focused drug development in PDUFA V."
"I know that in many ways, the African American community does not necessarily participate at high rates in drug testing."
"Moving from $23,600 to about $47,000, according to some studies, would cost about a half-a-million jobs in the economy."
"I certainly hope that you have already invested a lot of time contemplating what you would do as the next Secretary."
"I appreciate the Senator's questions."
"Thank you all on the panel for your dedication and your commitment to the welfare and the health of America and American citizens."
"In short, we are missing some opportunities."
"I think your answer, in many ways, reinforces the necessity of using those tools that are already in the market or ready to go to market as opposed to those that are still in the development stage, ac..."
"The pioneering work of Clemson researchers in the field of tissue bioprinting and the promise of that technology in the drug development and review process is a great example of the benefits of promot..."
"We are in desperate need of remapping."